Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
0.9999
+0.0400 (4.17%)
At close: Aug 13, 2025, 4:00 PM
0.9898
-0.0101 (-1.01%)
After-hours: Aug 13, 2025, 6:12 PM EDT
Allarity Therapeutics Employees
As of December 31, 2024, Allarity Therapeutics had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$3,429,429
Market Cap
15.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALLR News
- 4 weeks ago - Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization - GlobeNewsWire
- 5 weeks ago - Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer - GlobeNewsWire
- 6 weeks ago - Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer - GlobeNewsWire
- 2 months ago - Allarity Therapeutics Announces Changes to Board of Directors - GlobeNewsWire
- 3 months ago - Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment - GlobeNewsWire
- 4 months ago - ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - PRNewsWire
- 5 months ago - ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - PRNewsWire
- 5 months ago - Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission - GlobeNewsWire